Selecting outcome parameters in studies aimed at improving rational use of antibiotics - practical considerations.

Abstract:

:When designing studies of the optimal use of antimicrobial drugs, it is important to define at an early stage, which outcome parameters to use. It must be clear to which category a parameter to be measured belongs: the structure, the process or a clinical outcome. Attention must be paid to the measurement scales as well as the statistical tests to be used. The outcome measure must be sensitive, specific and reliable. Furthermore, the timeframe chosen for the performance of a study should be validated. Whether process parameters or clinical outcomes are to be preferred depends on the settings and the intended purpose. The essential point is the appropriate choice of outcome measure for the study. Examples drawn from the field of quality of use of antimicrobial drugs are discussed.

journal_name

J Clin Pharm Ther

authors

Natsch S,Kullberg BJ,Hekster YA,van der Meer JW

doi

10.1046/j.0269-4727.2003.00518.x

subject

Has Abstract

pub_date

2003-12-01 00:00:00

pages

475-8

issue

6

eissn

0269-4727

issn

1365-2710

pii

518

journal_volume

28

pub_type

杂志文章
  • Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin.

    abstract:WHAT IS KNOWN:The increased risk of cardiovascular events in diabetic patients has been related to numerous metabolic and haemoreological factors. Some of these factors appear to be particularly evident during the post-prandial phases and to be related to peak plasma glucose level. AIM:To compare the effect of additio...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1365-2710.2009.01132.x

    authors: Derosa G,Mereu R,D'Angelo A,Salvadeo SA,Ferrari I,Fogari E,Gravina A,Palumbo I,Maffioli P,Randazzo S,Cicero AF

    更新日期:2010-10-01 00:00:00

  • Pharmacokinetics and safety of bromotetrandrine (BrTet, W198) after single-dose intravenous administration in healthy Chinese volunteers.

    abstract:OBJECTIVE:To investigate the safety and pharmacokinetics of bromotetrandrine (BrTet, W198), a novel inhibitor of P-glycoprotein (P-gp), after single-dose i.v. infusion in healthy Chinese volunteers. METHODS:We conducted a randomized, dose-escalating, phase I clinical study for that purpose. Thirty healthy subjects rec...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1365-2710.2009.01075.x

    authors: Zheng L,Qing YP,Xu N,Yu Q,Wang Y,Wang FP,Li ZY

    更新日期:2010-02-01 00:00:00

  • Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.

    abstract:OBJECTIVE:A large number of structurally and functionally diverse compounds act as substrates or modulators of p-glycoprotein (p-gp). Some of them possess multiple drug resistance (MDR)-reversing activity, but only a small number of them have entered clinical study. In order to uncover the factors which exert a signifi...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1046/j.1365-2710.2003.00487.x

    authors: Wang RB,Kuo CL,Lien LL,Lien EJ

    更新日期:2003-06-01 00:00:00

  • Pharmacogenomic information in the Warning section of drug labels: A comparison between labels in the United States and those in five other countries/regions.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Clinically validated pharmacogenomic information useful for patient selection and/or dose adjustment is included in drug labels. However, the label information may differ among countries. This commentary summarizes the pharmacogenomic information on drug labels in different countries. COMME...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12691

    authors: Imatoh T,Sai K,Saito Y

    更新日期:2018-08-01 00:00:00

  • What do the suffixes--XR, ER, Chrono, Chronosphere--really mean as it pertains to modified-release antiepileptic drugs?

    abstract:BACKGROUND:Epilepsy is a disease requiring chronic therapy with antiepileptic drugs (AEDs). Many conventional AEDs currently available have either too rapid an absorption or elimination, requiring the patient to take multiple doses per day, which may adversely impact adherence or cause peak-related side-effects. Conseq...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2009.01117.x

    authors: Reed RC,Meinhold J,Dutta S,Liu W,Qiu Y

    更新日期:2010-08-01 00:00:00

  • Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Cytochrome P450 1A2 (CYP1A2), CYP2B6 and inducible nitric oxide synthase (iNOS) are involved in the metabolism and action of many important therapeutic drugs, and genetic variants have been associated with interethnic differences in response to treatment, including chemotherapy. METHODS:Eig...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12351

    authors: Qi GZ,Zhang ZY,Wang X,Yin SJ,Lou YQ,Zhang GL

    更新日期:2016-02-01 00:00:00

  • Stability of mupirocin ointment (Bactroban) admixed with other proprietary dermatological products.

    abstract::This study involved the mixing of 1:1 combinations of Bactroban (mupirocin) Ointment 2% with various cream, lotion, ointment, gel, solution and liquid soap formulations with storage at 37 degrees C for 60 days. The mixtures were assayed for mupirocin content at 0, 15, 30, 45 and 60 days using a high-pressure liquid ch...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.1992.tb01290.x

    authors: Jagota NK,Stewart JT,Warren FW,John PM

    更新日期:1992-06-01 00:00:00

  • The influence of Rx-to-OTC changes on drug sales. Experiences from Sweden 1980-1994.

    abstract:OBJECTIVE:A descriptive study of national sales data from Sweden to find out the effect of over-the-counter (OTC) switches on total sales of a number of drugs. During the period 1980-94, 16 drugs were changed from prescription only (Rx) status to the Swedish OTC market. Total sales increased for 14 out of these 16 drug...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.1996.tb00042.x

    authors: Carlsten A,Wennberg M,Bergendal L

    更新日期:1996-12-01 00:00:00

  • Potential novel targets for Alzheimer pharmacotherapy: I. Secretases.

    abstract::The prevailing major theory of Alzheimer's disease (AD) is that insoluble amyloid beta-peptide (Abeta) found in the cerebral plaques characteristic of the disease is causative or is at least a contributing factor. According to this theory, inhibition of aberrant Abeta production should prevent or at least limit the ex...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1046/j.1365-2710.2002.00415.x

    authors: Maiorini AF,Gaunt MJ,Jacobsen TM,McKay AE,Waldman LD,Raffa RB

    更新日期:2002-06-01 00:00:00

  • Re-elevation of serum amlodipine level after lipid emulsion therapy in an overdose case.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Amlodipine overdose is common; however, the dose and timing of intravenous lipid emulsion (ILE) therapy as a management strategy remain debatable. CASE DESCRIPTION:A 73-year-old man received a single bolus (1.5 mL/kg) of ILE therapy following massive ingestion of multiple drugs, including a...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type:

    doi:10.1111/jcpt.13018

    authors: Ando M,Nakasako S,Ariyoshi K,Yamaguchi M,Sakizono K,Minowa K,Fukushima S,Sugioka N,Hashida T

    更新日期:2019-12-01 00:00:00

  • Retinoic acid syndrome: a review.

    abstract::The retinoic acid syndrome (RAS) is an unpredictable but frequent complication which may develop after administration of all-trans retinoic acid (ATRA) most commonly in patients with acute promyelocytic leukaemia (APL). In this review, we describe the incidence, predictive factors, clinical course, outcome and treatme...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1365-2710.2008.00935.x

    authors: Patatanian E,Thompson DF

    更新日期:2008-08-01 00:00:00

  • Treatment of acute otitis media in patients with a reported penicillin allergy.

    abstract::Otitis media occurs commonly in children, and is usually treated with an antibiotic. In this case report, amoxicillin was prescribed for a 6-year-old boy suffering from acute otitis media. As he had previously experienced a rash after the administration of a penicillin, the medication order was switched from amoxicill...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1046/j.1365-2710.2000.00268.x

    authors: Falconer CL,Gardner DM

    更新日期:2000-06-01 00:00:00

  • Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.

    abstract::Pharmacokinetic interactions between antiepileptics represent a major potential complication of epilepsy treatment because drug combinations are common. This review discusses pharmacokinetic drug interactions of clinical significance involving antiepileptics and cytochrome P450 (CYP). Most commonly used antiepileptics...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1046/j.1365-2710.1999.00201.x

    authors: Tanaka E

    更新日期:1999-04-01 00:00:00

  • Pharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers.

    abstract::Flurbiprofen is a propionic acid-derived non-steroidal anti-inflammatory drug (NSAID) used widely in the treatment of rheumatism and non-arthritic pain. The pharmacokinetics of topically and orally administered flurbiprofen were compared in a two-part, open study involving healthy adult volunteers. In the first (cross...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2710.1995.tb00636.x

    authors: Taburet AM,Singlas E,Glass RC,Thomas F,Leutenegger E

    更新日期:1995-04-01 00:00:00

  • Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation programme.

    abstract:BACKGROUND:The anti-craving drug, naltrexone, is used as a pharmacotherapeutic adjunct in the treatment of alcohol dependence. In addictive disorders, compliance issues remain central. There are limited data on compliance with naltrexone treatment regimens within formalized rehabilitation programs and even less data th...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1046/j.1365-2710.2001.00326.x

    authors: Feeney GF,Connor JP,Young RM,Tucker J,Czajkowski F

    更新日期:2001-02-01 00:00:00

  • Steroids in multiple sclerosis.

    abstract::Steroids are widely used in treating the relapse of multiple sclerosis. There is no place for long term steroid therapy of this disease. Current practice is a short course of high dose methylprednisolone which can be repeated after an interval, has proven safety and objectively accelerates recovery. ...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验,评审

    doi:10.1111/j.1365-2710.1994.tb00677.x

    authors: Griffiths TD,Newman PK

    更新日期:1994-08-01 00:00:00

  • Determinants of prescribing costs amongst single-handed general practitioners.

    abstract:OBJECTIVE:To investigate the contribution of patient and doctor characteristics in explaining observed variations in prescribing costs between individual doctors. METHOD:Secondary analysis of data collected from general practitioners, Family Health Services Authorities, 1991 Census data set and the Prescription Pricin...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1046/j.1365-2710.2001.00371.x

    authors: Gill PS,Roalfe A

    更新日期:2001-12-01 00:00:00

  • Factors associated with the consumption of psychotropic drugs in a cohort of men and women aged 50 and over.

    abstract:OBJECTIVES:The use of psychotropic drugs has increased continuously over recent years in industrialized countries. In Europe, France has the highest consumption of such drugs. The aim of this study was to identify the sociodemographic and medical factors associated with the use of psychotropic agents. METHODS:Data, co...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1046/j.1365-2710.2003.00464.x

    authors: Empereur F,Baumann M,Alla F,Briançon S

    更新日期:2003-02-01 00:00:00

  • Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia.

    abstract:OBJECTIVE:There is a growing interest in investigating the role of glutamate receptors in the pathophysiology of schizophrenia. Indeed, the hyperdopaminergic theory of schizophrenia can explain only the positive symptoms of schizophrenia, whereas the glutamate hypothesis may provide a more comprehensive view of the ill...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2710.1999.00238.x

    authors: Noorbala AA,Akhondzadeh S,Davari-Ashtiani R,Amini-Nooshabadi H

    更新日期:1999-10-01 00:00:00

  • The effect of pharmacists on ward rounds measured by the STOPP/START tool in a specialized geriatric unit.

    abstract:WHAT IS KNOWN AND OBJECTIVE:The STOPP/START tool has been validated to assess elderly patients for potentially inappropriate prescribing. This study aimed to assess the effect of inclusion of a pharmacist on a physician-led ward round on potentially inappropriate prescribing in hospitalized elderly patients. METHODS:T...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12489

    authors: Mulvogue K,Roberts JA,Coombes I,Cottrell N,Kanagarajah S,Smith A

    更新日期:2017-04-01 00:00:00

  • Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Gabapentin has been used for the management of post-herpetic neuralgia (PHN). However, inconsistent results have been reported. This meta-analysis was performed to assess the efficacy and safety of gabapentin 1800 mg/day in PHN patients by conducting a meta-analysis. METHODS:Electronic data...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,meta分析,评审

    doi:10.1111/jcpt.12167

    authors: Fan H,Yu W,Zhang Q,Cao H,Li J,Wang J,Shao Y,Hu X

    更新日期:2014-08-01 00:00:00

  • Evaluation of once daily tobramycin dosing in critically ill patients through Bayesian simulation.

    abstract:OBJECTIVE:To evaluate if once-daily dose (ODD) regimens of tobramycin attain pharmacodynamic goals using individualized pharmacokinetic monitoring of critically ill patients with creatinine clearance (Clcr) over 60 mL/min. METHODS:Fifty-one adult critically ill patients treated with intravenous tobramycin with ODD wer...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2003.00539.x

    authors: Peris-Marti JF,Borras-Blasco J,Rosique-Robles JD,Gonzalez-Delgado M

    更新日期:2004-02-01 00:00:00

  • Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricaemia.

    abstract:WHAT IS KNOWN AND OBJECTIVE:There is much controversy over how angiotensin II receptor blockers (ARB) or angiotensin-converting enzyme inhibitors (ACEI) affect blood uric acid levels. Though ARB is not used to lorcwer the uric acid concentration in the blood, losartan, one of the ARB series, is known to reduce the uric...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.13202

    authors: Kim HS,Kim H,Lee SH,Kim JH

    更新日期:2020-12-01 00:00:00

  • Population pharmacokinetics of levetiracetam in neonates with seizures.

    abstract:WHAT IS KNOWN AND OBJECTIVE:This study developed a population pharmacokinetic (PK) model of levetiracetam (LEV) for treating neonatal seizures (NS) and determined the influence of clinically relevant covariates to explain the interindividual variability and residual error. METHODS:Twenty newborns admitted to the Neona...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12658

    authors: Lima-Rogel V,López-López EJ,Medellín-Garibay SE,Gómez-Ruiz LM,Romero-Méndez C,Milán-Segovia RC,Romano-Moreno S

    更新日期:2018-06-01 00:00:00

  • Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Midazolam (MDZ) is commonly used for sedating critically ill patients. The daily dose required for adequate sedation increases in increments over 100 h after administration. The objectives of this study were to characterize the MDZ pharmacokinetics in critically ill patients and to describe ...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12395

    authors: Aoyama T,Hirata K,Yamamoto Y,Yokota H,Hayashi H,Aoyama Y,Matsumoto Y

    更新日期:2016-08-01 00:00:00

  • Tumour necrosis factor-α gene -308 G > A and -238 G > A polymorphisms are associated with susceptibility to irritable bowel syndrome and drug efficacy in children.

    abstract:WHAT IS KNOWN AND OBJECTIVE:An imbalance in the genetically controlled pro- and anti-inflammatory cytokine production could potentially promote ongoing low-grade inflammation following an episode of acute gastroenteritis and, subsequently, could result in irritable bowel syndrome (IBS; post-infectious IBS, PI-IBS). Sin...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12775

    authors: Sun MH,Sun LQ,Guo GL,Zhang S

    更新日期:2019-04-01 00:00:00

  • Decitabine as a conditioning regimen in haploidentical stem cell transplantation for refractory acute myeloid leukaemia.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Chemotherapy can increase treatment-related mortality associated with future haematopoietic stem cell transplantation (HSCT) for patients with relapsed/refractory acute myeloid leukaemia (AML). There is usually insufficient time to find a suitable unrelated donor for these patients. We repor...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12251

    authors: Zhang C,Chen XH,Liu J,Gao L,Liu Y,Gao L,Kong PY,Zhang X

    更新日期:2015-06-01 00:00:00

  • Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Bisphosphonates are the first-line medications for treating osteoporosis. The aim of our prospective study was to compare the efficacy of zoledronate with that of alendronate in women with post-menopausal osteoporosis based on the evaluations of bone mineral density (BMD) and serum levels of...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/jcpt.12429

    authors: Tan W,Sun J,Zhou L,Li Y,Wu X

    更新日期:2016-10-01 00:00:00

  • Drug-induced parotitis.

    abstract::Drug-induced parotitis is a relatively uncommon adverse drug reaction. Most of the data on drug-induced parotitis consist of isolated case reports with few attempts at rechallenge to confirm the aetiology. Phenylbutazone and oxyphenbutazone have a significant number of reports suggesting that these drugs may be implic...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1365-2710.1993.tb00584.x

    authors: Thompson DF

    更新日期:1993-08-01 00:00:00

  • Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Alzheimer's disease (AD) is the most common cause of dementia among the elderly. The exact cause of the disease is not clearly known, and no existing therapies are able to prevent disease progression. Identification of the possible "impaired brain insulin signalling in AD" enriched the scope...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/jcpt.12808

    authors: Jojo GM,Kuppusamy G

    更新日期:2019-06-01 00:00:00